GlassScriptPhysician profile
Kristine M Eng
NPI 1811997828
$4,237.62
in general payments reported to CMS, 2019-2025
8 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $115 · 2021: $95.45 · 2022: $364 · 2023: $566 · 2024: $1,373 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,134 · Food and Beverage: $734 · Debt Forgiveness: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,134.27 |
| Food and Beverage | $734.37 |
| Debt Forgiveness | $547.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,583.72 | 2020-2025 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $1,443.36 | 2024-2025 | Infuse, Xiidra, Miebo |
| Optos, INC. | $720.00 | 2022-2023 | Panoramic Ophthalmoscope |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $227.03 | 2019 | |
| Heru, INC. | $165.36 | 2022 | |
| Alcon Vision LLC | $57.91 | 2024-2025 | Precision 1, Eysuvis |
| Visioneering Technologies, INC. | $20.23 | 2019 | |
| Sight Sciences, INC. | $20.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristine Eng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.